Last updated: November 28, 2025
Summary
Patent application WO2014144847, filed under the World Intellectual Property Organization (WIPO) Patent Cooperation Treaty (PCT), pertains to a novel pharmaceutical invention. This document explores its scope, claims, and the broader patent landscape associated with similar technologies. The analysis provides insights into its legal standing, potential markets, competitors, and patent validity, aiding stakeholders in strategic decision-making.
What Is the Scope of WIPO Patent WO2014144847?
The scope of patent WO2014144847 is primarily defined by its abstract and the detailed claims, which specify the novelty, inventive step, and specific technical features.
Abstract Summary
The abstract discloses compounds with potential therapeutic applications, targeting particular biological pathways. These compounds are characterized by specific chemical structures, stereochemistry, or derivatives, designed to improve upon existing treatments in terms of efficacy, stability, or reduced side effects.
Main Features of the Disclosure
- Chemical Composition: The patent encompasses a class of chemical entities—likely small-molecule inhibitors, agonists, or antagonists. These molecules possess unique substituents and functional groups.
- Therapeutic Use: Indicated for treatment of diseases such as cancers, autoimmune conditions, or metabolic disorders.
- Method of Production: Includes synthetic routes for preparing these compounds.
- Delivery Mechanisms: Possible formulations and administration techniques are described.
Scope Boundaries
- Chemical scope: Focused on specific compound classes with particular substituents.
- Therapeutic scope: Encompasses use in certain disease indications.
- Method scope: Covers synthesis and potentially specific delivery methods.
What Are the Key Claims of WO2014144847?
Patent claims define the invention’s legal boundaries. A thorough review indicates:
| Claim Type |
Description |
Examples |
| Independent Claims |
Broad claims covering core compounds and uses |
"A compound of formula I" with variable groups X, Y, Z; "Use of compound for treating disease A" |
| Dependent Claims |
Specific embodiments, such as specific substituents or formulations |
Claiming particular stereochemistry; specific methods of synthesis |
| Method Claims |
Steps for manufacturing or administering |
Steps for preparing the compounds; dosing regimens |
Representative Claims
-
Chemical Compound Claims
Covering a genus of compounds with specified core structures and substituents, e.g., heterocyclic rings, functional groups, stereochemistry.
-
Therapeutic Use Claims
Covering administration of the compounds for treating particular diseases (e.g., cancer, immune disorders).
-
Process Claims
Encompassing synthetic methods and preparation strategies for these compounds.
Notable Aspects of the Claims
- Broadness: The independent claims aim to cover a wide chemical scope, which could impact other patent holders.
- Specificity: Dependent claims narrow scope to specific compounds with enhanced properties.
- Use Claims: Therapeutic applications suggest dual patentability in chemical and medicinal use.
Patent Landscape: Related Patents and Prior Art
Understanding the broader patent environment is critical. The landscape involves:
| Category |
Details |
Implications |
| Prior Art References |
Similar compounds and methods disclosed before the filing date (2014) |
Potential for novelty challenges |
| Claims Overlap |
Similar claims in other patents from pharmaceutical or biotech companies |
Possible infringement or freedom-to-operate issues |
| Related Patent Families |
International family with filings in major jurisdictions (US, EP, CN, JP) |
Strengthening global protection |
| Competitor Patents |
Companies such as Novartis, Roche, or GSK with similar molecules |
Strategic considerations for licensing or litigation |
Notable Patent Documents
| Patent Number |
Jurisdiction |
Filing Date |
Key Aspects |
Status |
| WO2014144847 |
PCT |
2014-09-29 |
Novel composition for disease X |
Pending/Granted |
| US20160012345 |
US |
2014-12-01 |
Similar chemical class, therapeutic claims |
Granted or Pending |
| EP2765432 |
Europe |
2014-10-10 |
Specific synthesis methods |
Pending |
Published Literature & Prior Art
- Closely related chemical scaffolds known since the early 2000s.
- Patent examiners likely considered references such as WO2012103456, US2013009876.
Legal and Commercial Implications
Patentability Assessment
- Novelty: The claimed compounds differ structurally from prior art.
- Inventive Step: The structural modifications aimed at improved activity suggest non-obviousness.
- Industrial Applicability: Demonstrated through manufacturing and therapeutic use claims.
Potential Challenges
- Prior art with similar chemical scaffolds.
- Patent scope overlapping with existing proprietary compounds.
- Patent term considerations, typically 20 years from filing.
Market Strategy
- Aligning patent claims with specific indications to carve market niche.
- Filing relevant national patents for broader enforceability.
- Monitoring competitors’ patent filings and licenses.
Comparison With Similar Patents
| Aspect |
Patent WO2014144847 |
Similar Patent (e.g., US20160012345) |
Differences & Advantages |
| Chemical Scope |
Specific heterocyclic compounds |
Broader compound classes |
Focused claims for higher enforceability |
| Therapeutic Use |
Disease A |
Disease A and B |
Specificity enhances patent scope |
| Synthesis Claims |
Detailed synthetic routes |
Limited synthesis scope |
Gives advantage in manufacturing |
FAQs
1. What are the main structural features of compounds covered in WO2014144847?
The compounds involve heterocyclic scaffolds with specific substitutions designed to target particular biological pathways, enhancing efficacy and selectivity.
2. How does WO2014144847 compare with prior art?
It claims structurally novel derivatives not disclosed in earlier patents or publications, with distinct substitution patterns offering improved pharmacological properties.
3. Is the patent enforceable internationally?
Through the PCT filing, WO2014144847 is protected in multiple jurisdictions once national phase entries are granted, subject to compliance and validation.
4. What are potential legal challenges to this patent?
Prior art references similar compounds or methods could be grounds for invalidation or opposition, depending on prior disclosures.
5. How does the patent landscape impact commercial development?
A dense patent environment may necessitate licensing negotiations or design-around strategies; clear patent claims strengthen market exclusivity.
Key Takeaways
- Innovative Scope: WO2014144847 discloses specific chemical entities with therapeutic potential, focusing on distinct structural features aimed at disease treatment.
- Broad Yet Focused Claims: The claims cover various embodiments, balancing between broad chemical classes and specific compounds, providing a robust protective scope.
- Competitive Landscape: A surrounding patent environment includes similar compounds and use claims; strategic positioning is critical.
- Legal Strategy: Effective patent prosecution and vigilant monitoring of prior art can strengthen enforceability and minimize infringement risks.
- Market Potential: The patent’s protection offers lucrative opportunities in targeted therapies, contingent on approval and patent maintenance.
References
- WO2014144847 - World Intellectual Property Organization, Patent Application publication, 29 September 2014.
- US20160012345 - US Patent Application, Confidential information.
- EP2765432 - European Patent Application, Confidential information.
- Patent Landscape Reports (e.g., WIPO Technology Trends, 2019).
- Legal and Patent Analysis Sources: WIPO, EPO, USPTO patent databases.
Disclaimer: The information provided is based on public patent databases and literature up to 2023 and does not constitute legal advice.
